In the latest trading session,, 0.83 million Q32 Bio Inc (NASDAQ:QTTB) shares changed hands as the company’s beta touched -0.01. With the company’s most recent per share price at $1.50 changed hands at -$0.05 or -3.54% at last look, the market valuation stands at $18.30M. QTTB’s current price is a discount, trading about -3486.0% off its 52-week high of $53.79. The share price had its 52-week low at $1.38, which suggests the last value was 8.0% up since then. When we look at Q32 Bio Inc’s average trading volume, we note the 10-day average is 0.16 million shares, with the 3-month average coming to 208.13K.
Analysts gave the Q32 Bio Inc (QTTB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.33. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QTTB as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Q32 Bio Inc’s EPS for the current quarter is expected to be 0.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Instantly QTTB was in red as seen in intraday trades today. With action -21.05%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -56.40%, with the 5-day performance at -21.05% in the red. However, in the 30-day time frame, Q32 Bio Inc (NASDAQ:QTTB) is -9.09% down. Looking at the short shares, we see there were 0.87 million shares sold at short interest cover period of 4.11 days.
The consensus price target for the stock as assigned by Wall Street analysts is 64, meaning bulls need an upside of 97.66% from its recent market value. According to analyst projections, QTTB’s forecast low is 64 with 64 as the target high. To hit the forecast high, the stock’s price needs a -4166.67% plunge from its current level, while the stock would need to soar -4166.67% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 31.75%. The 2025 estimates are for Q32 Bio Inc earnings to increase by 36.17%, but the outlook for the next 5-year period is at 6.39% per year.
QTTB Dividends
Q32 Bio Inc is expected to release its next quarterly earnings report on 2025-Mar-10.
Q32 Bio Inc (NASDAQ:QTTB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.70% of Q32 Bio Inc shares while 79.82% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 87.43%. There are 79.82% institutions holding the Q32 Bio Inc stock share, with ORBIMED ADVISORS LLC the top institutional holder. As of 2024-06-30, the company held 18.831% of the shares, roughly 2.25 million QTTB shares worth $40.44 million.
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds the second largest percentage of outstanding shares, with 17.4863% or 2.09 million shares worth $37.55 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 190.8 shares estimated at $0.29 million under it, the former controlled 1.56% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.38% of the shares, roughly 167.95 shares worth around $0.26 million.
